Synthesis and pharmacological evaluation of 2,3-diphenyl acrylonitriles-bearing halogen as selective anticancer agents. 2018

Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
Key Laboratory of Natural Resources and Functional Molecules of the Changbai Mountain, Affiliated Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin Province, China.

Eighteen novel 2,3-diphenyl acrylonitrile derivatives bearing halogens were designed, synthesized, and evaluated for biological activity. Preliminary in vitro results indicated that the majority of the compounds with a para-substituted halogen had considerable antiproliferative activity against five human cancer cell lines, including MGC-803, AGS, and BEL-7402, with IC50 values in the range of 0.46-100 μm. No significant toxic effects on the non-cancerous human liver cell line L-02 were observed. The selective inhibitory activities against cancer cells were significantly better than that of the control lead compound CA-4 and CA-4P. Particularly, potent activities were found for the derivatives of 3-(4-halogen phenyl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile, such as 5c (4-fluoro), 5f (4-bromo), 5h (4-chloro), and 5k (4-trifluoro- methyl), for AGS with IC50 values of 0.75 ± 0.24, 0.68 ± 0.21, 0.41 ± 0.05, and 1.49 ± 0.92 μm, respectively. The antiproliferative effects of 5f were attributed to cell-cycle arrest in the G2 /M phase, induction of cellular apoptosis, suppression of cell migration, and inhibition of cell colony formation in AGS cells.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006219 Halogens A family of nonmetallic, generally electronegative, elements that form group 17 (formerly group VIIa) of the periodic table. Halogen,Group 17 Elements,Elements, Group 17
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000181 Acrylonitrile A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber. Vinyl Cyanide,Cyanide, Vinyl
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D059565 G2 Phase Cell Cycle Checkpoints CELL CYCLE regulatory signaling systems that are triggered by DNA DAMAGE or lack of nutrients during G2 PHASE. When triggered they restrain cells transitioning from G2 phase to M PHASE. Antephase Checkpoint,G2 Cell Cycle Arrest,G2 Cell Cycle Checkpoints,G2 Cell Cycle Control,G2 Phase Checkpoints,G2 Restriction Point,G2-M Cell Cycle Checkpoint,Antephase Checkpoints,Checkpoint, Antephase,Checkpoint, G2 Phase,Checkpoints, Antephase,Checkpoints, G2 Phase,G2 M Cell Cycle Checkpoint,G2 Phase Checkpoint,G2 Restriction Points,Restriction Point, G2,Restriction Points, G2
D059566 M Phase Cell Cycle Checkpoints The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will affect CHROMOSOME SEGREGATION is detected. M Phase Cell Cycle Checkpoint,M Phase Cell Cycle Arrest,M Phase Checkpoint,Mitotic Checkpoints,Mitotic Spindle Checkpoints,Spindle Assembly Checkpoint,Spindle Assembly Checkpoint Network,Assembly Checkpoint, Spindle,Assembly Checkpoints, Spindle,Checkpoint, M Phase,Checkpoint, Mitotic,Checkpoint, Mitotic Spindle,Checkpoint, Spindle Assembly,Checkpoints, M Phase,Checkpoints, Mitotic,Checkpoints, Mitotic Spindle,Checkpoints, Spindle Assembly,M Phase Checkpoints,Mitotic Checkpoint,Mitotic Spindle Checkpoint,Phase Checkpoint, M,Spindle Assembly Checkpoints,Spindle Checkpoint, Mitotic,Spindle Checkpoints, Mitotic

Related Publications

Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
November 2010, Bioorganic & medicinal chemistry letters,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
September 2015, European journal of medicinal chemistry,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
April 2014, Bioorganic chemistry,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
August 2012, European journal of medicinal chemistry,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
August 2018, Steroids,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
May 2019, Future medicinal chemistry,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
July 2023, Journal of biomolecular structure & dynamics,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
February 2010, Journal of medicinal chemistry,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
March 2014, Indian journal of pharmaceutical sciences,
Jia-Jun Li, and Jun Ma, and Ya-Bing Xin, and Zhe-Shan Quan, and Yu-Shun Tian
February 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!